Nima Movahedi is an associate in the Orange County office of Latham & Watkins.

Mr. Movahedi advises clients on mergers and acquisitions, venture capital, and emerging companies, capital markets, and corporate governance matters. 

He regularly advises private and public companies, private equity, and venture capital firms and financial institutions on general corporate matters and corporate transactions, including: 

  • Mergers and acquisitions 
  • Early-stage formation and corporate strategy 
  • Preferred stock, venture capital, and debt financings 
  • Public offerings of securities 
  • General corporate advice on day-to-day business matters 

Mr. Movahedi’s clients have included public and private companies in the life sciences, technology, financial services, aerospace, retail, and entertainment industries. 

In addition to representing life sciences, technology, financial services, aerospace, retail and entertainment companies on an ongoing basis, Mr. Movahedi’s representative transactions include advising the following companies:

Mergers & Acquisitions

  • Offerpad in its pending US$3 billion merger with Supernova Partners Acquisition Corporation
  • Owlet in its pending US$1.4 billion merger with Sandbridge Acquisition Corporation
  • Latch in its pending US$1.6 billion merger with TS Innovation Acquisitions Corp.
  • Talkspace in its pending US$1.6 billion merger with Hudson Executive Investment Corp.
  • Ouster in its US$1.9 billion merger with Colonnade Acquisition Corp.
  • GCM Grosvenor in its US$2 billion merger with CF Finance Acquisition Corp.
  • Cryoport in its US$320 million acquisition of the cryobiological products business of Chart Industries
  • Virgin Galactic in its US$1.5 billion merger with Social Capital Hedosophia Holdings
  • The Committee of Independent Directors of T-Mobile US in its US$146 billion merger between T-Mobile US and Sprint
  • Impact Biomedicines in its up to US$7 billion sale to Celgene
  • PIMCO in its acquisition of Gurtin Municipal Bond Management
  • ICU Medical in its US$900 million acquisition of the Hospira Infusion Systems business of Pfizer 
  • Breathe Technologies in its sale to Hill-Rom for US$130 million
  • Mission Lane in its acquisition of the credit cards business of LendUp
  • Putney in its US$200 million sale to Dechra Pharmaceuticals 

VC / Emerging Companies

  • Invus Opportunities in several equity and debt investments totaling over US$300 million
  • Novo Ventures in several equity and debt investments totaling over US$50 million
  • Evergent Technologies in its equity financing led by TZP Group
  • Relievant Medsystems in its US$58 million equity financing led by Endeavour
  • Indigo Ag in several rounds of financing totaling over US$150 million

Capital Markets

  • Amgen in its US$3.2 billion investment in BeiGene
  • Cryoport in its US$275 million private placement with Blackstone
  • Switch in its US$610 million IPO 
  • Redwood Trust in its offering of US$245 million in convertible senior notes 
  • Jefferies in connection with the IPO of Aclaris Therapeutics

Bar Qualification

  • California


  • J.D., Boston University School of Law
    cum laude
  • BA, University of California, Los Angeles
    Dean's List

Languages Spoken

  • English
  • Farsi (Persian)